# Jamie Goldstein > Jamie Goldstein is a seed investor at Petri (Boston) backing Artificial Intelligence and Software. See 69 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [Petri](https://shizune.co/investors/profile/petri-bio) - Location: Boston, United States - Total investments: 69 - Last investment: Dec 2025 - Lead investor: 13% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/in/jamiegoldstein1 - X (Twitter): https://twitter.com/jamieagoldstein - Website: https://x.com/jamieagoldstein - Facebook: https://www.facebook.com/jamiegoldstein44 Jamie Goldstein is a seed investor at Petri in Boston focused on Artificial Intelligence and Software. Jamie Goldstein is the Founding Partner of Pillar VC. He previously worked at LBRY as a Board Member and Investor. Jamie Goldstein attended Massachusetts Institute of Technology. ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Artificial Intelligence | 8 | 12% | | Software | 7 | 10% | | Health Care | 7 | 10% | | Biotechnology | 7 | 10% | | Information Technology | 7 | 10% | 77 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Seed | 22 | 32% | | Series A | 12 | 17% | | Series B | 9 | 13% | | Series C | 5 | 7% | | Funding Round | 4 | 6% | 12 stages tracked in total. ### Country | Country | Investments | Share | | --- | --- | --- | | United States | 35 | 51% | | United Kingdom | 1 | 1% | | The Netherlands | 1 | 1% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Addis Energy | Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production. | $8.3M | Seed | Dec 01, 2025 | | | Matterworks | Matterworks accelerates the discovery and engineering through faster and more comprehensive metabolomic screening. | | Series A | Jun 03, 2025 | | | LightSource | LightSource develops a supply chain management platform to help professionals collaborate with their suppliers. It also allows collaborating with teammates on strategic sourcing projects, sending RFQs to suppliers and collecting quotes, and comparing bids using insights automatically extracted from the normal day-to-day work.The company wasfounded in 2021 and is headquartered in San Francisco, California. | $33M | Series A | Mar 31, 2025 | | | Videa | VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping dentists avoid missing diseases and effectively communicating treatment recommendations to patients. Today, dentists miss up to 50% of pathologies in dental x-rays. Treatment delays or non-treatment often results in significant health risks forthe patient and a loss of revenue for the dentists as he cannot treat missed diseases. | $40M | Series B | Jan 28, 2025 | | | Addis Energy | Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production. | $4.3M | Pre-Seed | Jan 21, 2025 | | | Adaptilens | Adaptilens develop an accommodating intraocular lens. Adaptilen's mission is to bring to market an accommodative intraocular lens that mimics the natural human lens so that patients will have excellent near and distance vision without eyeglasses or contact lenses. | $17.5M | Series A | Apr 29, 2024 | | | Asimov | Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies. | $175M | Series B | Jan 05, 2023 | | | Abridge | Abridge provides an AI platform that transforms patient-clinician conversations into structured, billable clinical notes. This technology aims to reduce documentation burdens for clinicians and nurses. The system integrates into existing healthcare workflows and electronic health record systems. | $12.5M | Series A | Aug 11, 2022 | | | AnyQuestion | You ask the questions, the world’s top experts share their answers. | | Seed | Apr 01, 2022 | | | Videa | VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping dentists avoid missing diseases and effectively communicating treatment recommendations to patients. Today, dentists miss up to 50% of pathologies in dental x-rays. Treatment delays or non-treatment often results in significant health risks forthe patient and a loss of revenue for the dentists as he cannot treat missed diseases. | $20M | Series A | Mar 31, 2022 | | 10 of 69 investments shown. ## Co-investors - [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 7 deals together - [Highland Capital Partners](https://shizune.co/investors/profile/highland-capital-partners) — VC Fund, 7 deals together - [Intersouth Partners](https://shizune.co/investors/profile/intersouth-partners) — VC Fund, 6 deals together - [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 5 deals together - [eLab Ventures](https://shizune.co/investors/profile/michigan-elab) — VC Fund, 5 deals together - [Polaris Partners](https://shizune.co/investors/profile/polaris-partners) — VC Fund, 5 deals together ## About Petri VC Fund · Boston, United States Petri is a new approach for funding formation-stage startups at the intersection of biology and engineering. Petri is co-founded by entrepreneurs who have built iconic companies as well as academics who are driving foundational science in bioengineering; together we have deep experience developing ideas into successful companies across humanhealth and sustainability.We invest pre-seed and seed capital and work one-on-one with founders for 12+ months. We help founders build world-class teams, develop intellectual property, find customers, and raise a subsequent round of financing. 5 contacts available at Petri. | Name | Title | Profile | | --- | --- | --- | | Brian Baynes | Founder | https://shizune.co/investors/profile/brian-baynes | | Jamie Goldstein | Founder and Chairman | https://shizune.co/investors/profile/jamie-goldstein | | Jaye Goldstein | Head of Program | https://shizune.co/investors/profile/jaye-goldstein | | Josh Moser | Partner | https://shizune.co/investors/profile/josh-moser | | Tony Kulesa | Founder, Partner | https://shizune.co/investors/profile/tony-kulesa-f829 | ## Similar investors ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund ## FAQ ### What does Jamie Goldstein invest in? Jamie Goldstein invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Seed and Series A stage. Most of the 69 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### When did Jamie Goldstein last invest? The most recent investment recorded for Jamie Goldstein closed in Dec 2025. Shizune tracks 69 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co